Your browser doesn't support javascript.
loading
Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2- Breast Cancer.
Dowsett, Mitch; Kilburn, Lucy; Rimawi, Mothaffar F; Osborne, C Kent; Pogue-Geile, Katherine; Liu, Yuan; Jacobs, Samuel A; Finnigan, Melanie; Puhalla, Shannon; Dodson, Andrew; Martins, Vera; Cheang, Maggie; Perry, Sophie; Holcombe, Chris; Turner, Nick; Swift, Claire; Bliss, Judith M; Johnston, Stephen.
Affiliation
  • Dowsett M; Royal Marsden Hospital, London, United Kingdom. Mitch.dowsett@icr.ac.uk.
  • Kilburn L; Breast Cancer Now Toby Robins Center for Breast Cancer Research, Institute of Cancer Research, London, United Kingdom.
  • Rimawi MF; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, United Kingdom.
  • Osborne CK; Baylor College of Medicine, Houston, Texas.
  • Pogue-Geile K; Baylor College of Medicine, Houston, Texas.
  • Liu Y; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Jacobs SA; Pfizer, New York, New York.
  • Finnigan M; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Puhalla S; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Dodson A; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Martins V; University of Pittsburgh Medical Center Cancer Center, Pittsburgh, Pennsylvania.
  • Cheang M; Royal Marsden Hospital, London, United Kingdom.
  • Perry S; Royal Marsden Hospital, London, United Kingdom.
  • Holcombe C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, United Kingdom.
  • Turner N; Clinical Trials and Statistics Unit, The Institute of Cancer Research, Sutton, United Kingdom.
  • Swift C; Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool, United Kingdom.
  • Bliss JM; Royal Marsden Hospital, London, United Kingdom.
  • Johnston S; Breast Cancer Now Toby Robins Center for Breast Cancer Research, Institute of Cancer Research, London, United Kingdom.
Clin Cancer Res ; 28(1): 163-174, 2022 01 01.
Article in En | MEDLINE | ID: mdl-34645649

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United States